Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?
Tamiya M, Tamiya A, Suzuki H, Moriizumi K, Nakahama K, Taniguchi Y, Kunimasa K, Kimura M, Inoue T, Kuhara H, Nishino K, Hirashima T, Atagi S, Imamura F, Kumagai T.
Tamiya M, et al. Among authors: moriizumi k.
Anticancer Res. 2019 Jul;39(7):3923-3929. doi: 10.21873/anticanres.13544.
Anticancer Res. 2019.
PMID: 31262922